Related Experiment Video
Updated: May 16, 2026
10:30
A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy
Published on: May 16, 2015
Incontinentia pigmenti presenting as encephalopathy
Vykuntaraju K N Gowda1, Chandra Mouly, Asthik Biswas
1Indira Gandhi Institute of Child Health, Bangalore, Karnataka, India, drknvraju@hotmail.com.
Indian Journal of Pediatrics
|November 27, 2012
Summary
Incontinentia Pigmenti is a rare genetic disorder causing skin issues and neurological problems. This case highlights its presentation in infancy with encephalopathy and brain infarcts, leading to a confirmed diagnosis.
Area of Science:
- Genetics
- Neurology
- Dermatology
Background:
- Incontinentia Pigmenti (IP) is a rare, inherited neurocutaneous disorder.
- It typically manifests with characteristic skin lesions and can involve neurological complications.
- Early diagnosis is crucial for managing potential developmental and neurological sequelae.
Observation:
- A two-month-old infant presented with a distinctive rash and signs of encephalopathy.
- Cerebral magnetic resonance imaging (MRI) revealed evidence of hemorrhagic infarcts.
- Initial clinical suspicion pointed towards a skin infection with meningoencephalitis.
Findings:
- The development of characteristic skin lesions, alongside neuroimaging and skin biopsy findings, prompted a diagnostic reevaluation.
- The clinical presentation and diagnostic workup were ultimately consistent with Incontinentia Pigmenti.
- This case underscores the importance of considering IP in infants with unexplained encephalopathy and skin manifestations.
Implications:
- This case emphasizes the critical role of recognizing the diverse clinical spectrum of Incontinentia Pigmenti, particularly in neonates and infants.
- Accurate and timely diagnosis of IP is essential for appropriate patient management and genetic counseling.
- Further research into the neurodevelopmental outcomes and long-term prognosis of affected individuals is warranted.
More Related Videos
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
07:50A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Related Concept Videos
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...